It will be useful to examine marks such as H3K4me1 and H3K4me2 as well as H3K9ac, H3K27ac and H4ac to support the cell-specificity and activation stage of SLC11A1 predicted 5' enhancer domain in APL cells. Here, SLC11A1 is linked to acute promyelocytic leukemia.